by Plus Therapeutics | Dec 17, 2024 | LM
Plus Therapeutics Presents Positive ReSPECT-LM Phase 1 Interim Data at 2024 San Antonio Breast Cancer Symposium (SABCS) ICYMI: Plus Therapeutics presented our ReSPECT-LM Phase 1 interim data for Breast Cancer patients with Leptomeningeal Metastases at the 2024 San...
by Plus Therapeutics | Dec 16, 2024 | GBM
COMING SOON: A Glioblastoma Survivor’s Journey with ReSPECT-GBM This week, we are thrilled to share a BRAND NEW patient testimonial from Jim, a courageous individual who has been navigating the challenges of recurrent glioblastoma. In this powerful video, Jim...
by Plus Therapeutics | Dec 11, 2024 | LM
Reminder: Visit Plus Therapeutics at #SABCS2024 in San Antonio – Booth #1542! Join us at #SABCS2024 in San Antonio, Texas, where Plus Therapeutics will be showcasing its groundbreaking work in targeted radiation therapy for central nervous system cancers including...
by Plus Therapeutics | Dec 9, 2024 | LM
⏯️ 🧠 Now Streaming: Replay the Live Symposium by Plus Therapeutics at #SNO2024 Annual Conference Catch up on the latest advancements in leptomeningeal disease and cancer therapeutics! The live symposium presented by Plus Therapeutics at the #SNO2024 Annual Meeting is...
by Plus Therapeutics | Dec 5, 2024 | LM
🎗️ Now Streaming: A ReSPECT-LM Patient Story | Marlyn, Leptomeningeal Metastases Survivor ⏯️ Watch her inspiring journey on YouTube: A ReSPECT-LM Patient Story: Marlyn’s Journey At the age of 31, while immersed in her Medical Residency for Pediatrics, Dr. Marlyn...
Recent Comments